NORTHERN TRUST CORP - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 29 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,839
-29.8%
26,0490.0%0.00%
Q2 2023$29,696
-24.0%
26,0490.0%0.00%
Q1 2023$39,074
+0.7%
26,0490.0%0.00%
Q4 2022$38,813
-3.0%
26,0490.0%0.00%
Q3 2022$40,000
+14.3%
26,049
+67.6%
0.00%
Q2 2022$35,000
-90.2%
15,542
-89.9%
0.00%
Q1 2022$356,000
-61.6%
154,161
-3.6%
0.00%
Q4 2021$928,000
-45.1%
159,861
-0.6%
0.00%
Q3 2021$1,691,000
+130.7%
160,758
+114.3%
0.00%
Q2 2021$733,000
-38.4%
75,011
-8.5%
0.00%
Q1 2021$1,190,00081,9470.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$580,0000.02%
Virtu Financial LLC 15,980$93,0000.01%
Jump Financial, LLC 11,800$68,0000.00%
Investment Research & Advisory Group, Inc. 1,400$4,0000.00%
Cubist Systematic Strategies, LLC 12,804$74,0000.00%
UBS Group AG 22,402$130,0000.00%
RHUMBLINE ADVISERS 18,894$110,0000.00%
Ellevest, Inc. 18$00.00%
TWO SIGMA INVESTMENTS, LP 28,771$167,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,105$64,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders